Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers

• Published in: The international journal of neuropsychopharmacology Vol. 16; no. 5; pp. 957 - 966
• Main Authors: Brody, Arthur L., Mukhin, Alexey G., La Charite, Jaime, Ta, Karen, Farahi, Judah, Sugar, Catherine A., Mamoun, Michael S., Vellios, Evan, Archie, Meena, Kozman, Maggie, Phuong, Jonathan, Arlorio, Franca, Mandelkern, Mark A.
• Format: Journal Article
• Language: English
• Published: Cambridge, UK Cambridge University Press 01.06.2013; Oxford University Press
• Subjects: Adult; Analysis of Variance; Azetidines - pharmacology; Brain - diagnostic imaging; Brain - drug effects; Brain Mapping; Female; Fluorine Radioisotopes; Humans; Male; Menthol - administration & dosage; Middle Aged; Positron-Emission Tomography; Receptors, Nicotinic - metabolism; Smoking - blood; Smoking - pathology; Up-Regulation - drug effects; tobacco; nicotine dependence; positron emission tomography; Age; nicotinic acetylcholine receptor
• ISSN: 1461-1457; 1469-5111
• DOI: 10.1017/S1461145712001022

One-third of smokers primarily use menthol cigarettes and usage of these cigarettes leads to elevated serum nicotine levels and more difficulty quitting in standard treatment programmes. Previous brain imaging studies demonstrate that smoking (without regard to cigarette type) leads to up-regulation of β2*-containing nicotinic acetylcholine receptors (nAChRs). We sought to determine if menthol cigarette usage results in greater nAChR up-regulation than non-menthol cigarette usage. Altogether, 114 participants (22 menthol cigarette smokers, 41 non-menthol cigarette smokers and 51 non-smokers) underwent positron emission tomography scanning using the α4β2* nAChR radioligand 2-[18F]fluoro-A-85380 (2-FA). In comparing menthol to non-menthol cigarette smokers, an overall test of 2-FA total volume of distribution values revealed a significant between-group difference, resulting from menthol smokers having 9–28% higher α4β2* nAChR densities than non-menthol smokers across regions. In comparing the entire group of smokers to non-smokers, an overall test revealed a significant between-group difference, resulting from smokers having higher α4β2* nAChR levels in all regions studied (36–42%) other than thalamus (3%). Study results demonstrate that menthol smokers have greater up-regulation of nAChRs than non-menthol smokers. This difference is presumably related to higher nicotine exposure in menthol smokers, although other mechanisms for menthol influencing receptor density are possible. These results provide additional information about the severity of menthol cigarette use and may help explain why these smokers have more trouble quitting in standard treatment programmes.